![Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting](https://www.seventure.fr/wp-content/uploads/2020/07/10_104270789-322x211.jpg)
Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
Vedanta Biosciences, a clinical-stage biopharmaceutical company pioneering the development of oral therapies based on defined bacterial consortia, today announced the details...